Alphabet as of Dec. 31, 2024
Portfolio Holdings for Alphabet
Alphabet holds 40 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gitlab Class A Com (GTLB) | 20.0 | $343M | 6.1M | 56.35 | |
| Freshworks Class A Com (FRSH) | 15.3 | $262M | 16M | 16.17 | |
| Arm Holdings Sponsored Ads (ARM) | 14.1 | $242M | 2.0M | 123.36 | |
| Revolution Medicines (RVMD) | 10.5 | $181M | 4.1M | 43.75 | |
| Crowdstrike Hldgs Cl A (CRWD) | 8.5 | $146M | 428k | 342.16 | |
| Planet Labs Pbc Com Cl A (PL) | 7.5 | $129M | 32M | 4.04 | |
| Uipath Cl A (PATH) | 5.2 | $89M | 7.0M | 12.71 | |
| Dex (DXCM) | 4.7 | $81M | 1.0M | 77.74 | |
| Verve Therapeutics (VERV) | 4.0 | $70M | 12M | 5.63 | |
| Tempus Ai Cl A (TEM) | 3.0 | $52M | 1.6M | 33.76 | |
| Prime Medicine (PRME) | 2.6 | $44M | 15M | 2.92 | |
| Vera Therapeutics Cl A (VERA) | 0.6 | $10M | 241k | 42.29 | |
| Monte Rosa Therapeutics (GLUE) | 0.6 | $10M | 1.5M | 6.94 | |
| Beam Therapeutics (BEAM) | 0.5 | $8.0M | 322k | 24.80 | |
| Oscar Health Cl A (OSCR) | 0.4 | $6.5M | 482k | 13.44 | |
| Relay Therapeutics (RLAY) | 0.4 | $6.5M | 1.6M | 4.12 | |
| Sana Biotechnology (SANA) | 0.3 | $4.6M | 2.8M | 1.63 | |
| Dianthus Therapeutics (DNTH) | 0.3 | $4.5M | 209k | 21.80 | |
| Lyell Immunopharma | 0.2 | $3.8M | 5.9M | 0.64 | |
| Tscan Therapeutics (TCRX) | 0.2 | $3.3M | 1.1M | 3.04 | |
| Desktop Metal Com Cl A (DM) | 0.2 | $2.6M | 1.1M | 2.34 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $2.4M | 501k | 4.72 | |
| Barinthus Biotherapeutics Pl Ads (BRNS) | 0.1 | $1.8M | 1.5M | 1.21 | |
| Genedx Holdings Corp (WGS) | 0.1 | $1.7M | 23k | 76.86 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $1.6M | 698k | 2.35 | |
| Kronos Bio | 0.1 | $1.4M | 1.4M | 0.95 | |
| Fractyl Health (GUTS) | 0.1 | $1.4M | 663k | 2.06 | |
| Tenaya Therapeutics (TNYA) | 0.1 | $1.3M | 916k | 1.43 | |
| EXACT Sciences Corporation (EXAS) | 0.1 | $1.3M | 23k | 56.21 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.1M | 641k | 1.73 | |
| Spero Therapeutics (SPRO) | 0.1 | $917k | 890k | 1.03 | |
| Benson Hill Com New (BHILQ) | 0.1 | $864k | 439k | 1.97 | |
| Hyperfine Com Cl A (HYPR) | 0.0 | $791k | 899k | 0.88 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.0 | $614k | 449k | 1.37 | |
| Cortexyme (QNCX) | 0.0 | $354k | 189k | 1.87 | |
| Alector (ALEC) | 0.0 | $332k | 176k | 1.89 | |
| Fulcrum Therapeutics (FULC) | 0.0 | $67k | 14k | 4.71 | |
| Repligen Corporation (RGEN) | 0.0 | $55k | 383.00 | 144.04 | |
| Invitae (NVTAQ) | 0.0 | $0 | 236k | 0.00 | |
| Cue Health (HLTHQ) | 0.0 | $0 | 27k | 0.00 |
